The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

Progress in the research and therapy of adult acute lymphoblastic leukemia (ALL) is accelerating. This analysis summarizes the data derived from the clinical trials conducted at MD Anderson between 1985 and 2022 across ALL subtypes. In Philadelphia chromosome-positive ALL, the addition of BCR::ABL1...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabbour, Elias, Short, Nicholas J., Jain, Nitin, Haddad, Fadi G., Welch, Mary Alma, Ravandi, Farhad, Kantarjian, Hagop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018889/
https://www.ncbi.nlm.nih.gov/pubmed/36927623
http://dx.doi.org/10.1186/s13045-023-01409-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018889/
https://www.ncbi.nlm.nih.gov/pubmed/36927623
http://dx.doi.org/10.1186/s13045-023-01409-5

Ejemplares similares